- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Mi | Aterian, Inc: Aterian Reports 2025 First Quarter Financial Results | 298 | SUMMIT, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) ("Aterian" or the "Company"), a consumer products company, today announced financial results for the first quarter ended... ► Artikel lesen | ||
| Mi | Castor Maritime Inc. Reports Fourth Quarter and Full Year Results for 2024 | 37 | LIMASSOL, Cyprus, May 14, 2025 (GLOBE NEWSWIRE) -- Castor Maritime Inc. (NASDAQ: CTRM) ("Castor" or the "Company"), a diversified global shipping and energy company, today announced its results for... ► Artikel lesen | ||
| Mi | Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination | 17 | WILMINGTON, Del., May 14, 2025 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. ("Bannix") announced today that its board of directors (the "Board") has decided to extend the date by which Bannix must... ► Artikel lesen | ||
| Mi | Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results | 36 | ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 30, 2025. Fourth Quarter Fiscal... ► Artikel lesen | ||
| Mi | Lulu's Fashion Lounge Holdings, Inc.: Lulus Reports First Quarter 2025 Results | 33 | Significant Improvement in Liquidity with $1.4M Increase in Cash Provided by Operating Activities and $1.8M Increase in Free Cash Flow, Both Compared to Q1'24 Reduced Total Debt by $3.0M and Net Debt... ► Artikel lesen | ||
| Mi | The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance | 27 | CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States... ► Artikel lesen | ||
| Mi | Fossil Group, Inc. Reports First Quarter 2025 Financial Results | 34 | RICHARDSON, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- First quarter worldwide net sales totaled $233 million Gross margin expanded 890 basis points to 61.3% First quarter operating loss of $7 million... ► Artikel lesen | ||
| Mi | Silo Pharma, Inc.: Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15 | 62 | SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery... ► Artikel lesen | ||
| Mi | IREN Reports Q3 FY25 Results | 60 | 28% Growth in Profit After Tax Horizon 1 AI Data Center on Track for H2 2025 Pausing Mining Expansion at 50 EH/s to Focus on AI Opportunities SYDNEY, May 14, 2025 (GLOBE NEWSWIRE) -- IREN Limited... ► Artikel lesen | ||
| Mi | USA Rare Earth, Inc.: USA Rare Earth Reports its First Quarter 2025 Financial Results | 44 | STILLWATER, Okla., May 14, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) ("USAR" or the "Company") today announced its financial results for the first quarter ended March?31, 2025.... ► Artikel lesen | ||
| Mi | Acrivon Therapeutics, Inc: Acrivon Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights | 37 | Corporate R&D event highlighted positive ACR-368 data in endometrial cancer patients who had all received prior anti-PD-1 and platinum-based chemotherapy Confirmed overall response rate (cORR) of... ► Artikel lesen | ||
| Mi | Aardvark Therapeutics, Inc.: Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights | 30 | Phase 3 HERO trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS); data readout expected in early 2026$151.3 million in cash, cash equivalents, and short-term... ► Artikel lesen | ||
| Mi | GENFIT S.A.: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024) | 226 | Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 14, 2025- GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients... ► Artikel lesen | ||
| Mi | Galapagos NV: Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101 | 237 | Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation... ► Artikel lesen | ||
| Mi | F. Hoffmann-La Roche Ltd: Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis | 350 | The VENTANA MET (SP44) RxDx Assay detects the MET (also known as c-Met) protein, which is over-expressed in some patients with non-squamous non-small cell lung cancer (NSQ-NSCLC).The MET protein serves... ► Artikel lesen | ||
| Mi | WillScot Announces Investor Conference Schedule for June 2025 | 200 | PHOENIX, May 14, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation ("WillScot" or the "Company") (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that it will participate... ► Artikel lesen | ||
| Mi | smartShift Revolutionizes SAP Modernization with AI-Powered Revert to Standard | 242 | Poised to Redefine SAP ERP Modernization, smartShift Unveils AI-Powered Platform to Accelerate Revert to Standard.Boston, MA, May 14, 2025 (GLOBE NEWSWIRE) -- smartShift, a global leader in SAP custom... ► Artikel lesen | ||
| Mi | Birchcliff Energy Ltd. Announces Strong Q1 2025 Results and Declares Q2 2025 Dividend | 193 | CALGARY, Alberta, May 14, 2025 (GLOBE NEWSWIRE) -- Birchcliff Energy Ltd. ("Birchcliff" or the "Corporation") (TSX: BIR) is pleased to announce its Q1 2025 financial and operational results. Chris... ► Artikel lesen | ||
| Mi | Usio, Inc.: Usio Announces First Quarter 2025 Financial Results | 117 | Record First Quarter Revenues of $22.0 million Total payment dollars processed through all payment channels up 34% versus the prior year period SAN ANTONIO, May 14, 2025 (GLOBE NEWSWIRE) --... ► Artikel lesen | ||
| Mi | BridgeBio Pharma, Inc.: BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 16 | PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, today... ► Artikel lesen | ||
| Mi | Nkarta, Inc.: Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights | 109 | Enrollment open in investigator-sponsored trial (IST) of NKX019 in myasthenia gravis; Ntrust-1, Ntrust-2, and IST of NKX019 in systemic lupus erythematosus remain open to enrollment Ntrust-1 expanded... ► Artikel lesen | ||
| Mi | Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update | 29 | The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment... ► Artikel lesen | ||
| Mi | Eledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results | 29 | On track to report topline results from Phase 2 BESTOW trial in kidney transplantation in fourth quarter of 2025 Tegoprubart used as a key component of immunosuppression regimen in its second transplant... ► Artikel lesen | ||
| Mi | Bionano Genomics: Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress | 43 | SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. "The first quarter of 2025 represents... ► Artikel lesen | ||
| Mi | Monogram Technologies Inc.: Monogram Technologies Reports First Quarter 2025 Financial Results | 25 | Receives FDA Clearance for the mBôs TKA System Groundbreaking Trial Set to Deliver one of the World's First Autonomous Saw-Based Robotic TKA Surgeries on Live Patients Management to Host Business... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .